Market Indices
Sector Heatmap
IMNM — Immunome, Inc.
NasdaqImmunome, Inc.
- O
- 20.79
- H
- 21.48
- L
- 20.67
- V
- 1.22M
IMNM — Latest News & Headlines
10 StoriesImmunome, Inc. (IMNM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Immunome, Inc. (IMNM) Stock Price, News, Quote & History Yahoo! Finance Canada
Immunome Stock Price Forecast. Should You Buy IMNM? - StockInvest.us
Immunome Stock Price Forecast. Should You Buy IMNM? StockInvest.us
Immunome (IMNM) Stock May Be A Bargain After IM 1340 Clearance - Simply Wall Street
Immunome (IMNM) Stock May Be A Bargain After IM 1340 Clearance Simply Wall Street
FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. - Stock Titan
FDA clears Immunome to test a cancer drug in people; a study is expected in the fourth quarter of 2026. Stock Titan
Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues - Yahoo Finance
Immunome (IMNM) Stock Looks Near Fair Value As Its 186% Run Continues Yahoo Finance
Price-Driven Insight from (IMNM) for Rule-Based Strategy - Stock Traders Daily
Price-Driven Insight from (IMNM) for Rule-Based Strategy Stock Traders Daily
Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Ad - GuruFocus
Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Ad GuruFocus
IMNM Initiated Coverage by Stifel -- Rated Hold with PT at $24.0 - GuruFocus
IMNM Initiated Coverage by Stifel -- Rated Hold with PT at $24.0 GuruFocus
Immunome stock gets FDA clearance for fifth clinical program - AD HOC NEWS
Immunome stock gets FDA clearance for fifth clinical program AD HOC NEWS
Immunome Restructures BMS Deal, Gains Key Patent Rights - TipRanks
Immunome Restructures BMS Deal, Gains Key Patent Rights TipRanks